We are live on ! Find out more
QTTB icon

Q32 Bio

58 hedge funds and large institutions have $20.8M invested in Q32 Bio in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $15.9M → $20.8M (+$4.94M)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

0.01% less ownership

Funds ownership: 1.72%1.71% (-0.01%)

2% less funds holding

Funds holding: 5958 (-1)

78% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 18

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
18
Closed
6
Calls
$75K
Puts
Net Calls
+$75K
Net Calls Change
+$35K

QTTB Hedge Fund Activity: Q3 2023 in Review

58 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2023, worth a combined $20.8M — up 31% from $15.9M a quarter earlier.

Fund positioning in QTTB was balanced in Q3 2023: 6 funds opened new positions, 6 closed out, 4 added to existing stakes and 18 trimmed.

The largest buyer was Western Standard LLC, opening a new position worth an estimated $283K. The largest seller was Bank of America, cutting an estimated $145K.

  • 58 institutional investors held Q32 Bio (QTTB) as of Q3 2023, down from 59 in Q2 2023.
  • Funds reported $20.8M of Q32 Bio stock for Q3 2023, up 31% quarter-over-quarter.
  • 6 funds opened new Q32 Bio positions in Q3 2023 and 6 closed out, a net change of 0 holders.
  • The largest Q32 Bio buyer in Q3 2023 was Western Standard LLC, an estimated $283K added.
  • The largest Q32 Bio seller in Q3 2023 was Bank of America, an estimated $145K sold.

Based on aggregated 13F filings for Q3 2023.